• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Narrative review: paroxysmal nocturnal hemoglobinuria: the physiology of complement-related hemolytic anemia.

作者信息

Brodsky Robert A

机构信息

Division of Hematology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205-2196, USA.

出版信息

Ann Intern Med. 2008 Apr 15;148(8):587-95. doi: 10.7326/0003-4819-148-8-200804150-00003.

DOI:10.7326/0003-4819-148-8-200804150-00003
PMID:18413620
Abstract
摘要

相似文献

1
Narrative review: paroxysmal nocturnal hemoglobinuria: the physiology of complement-related hemolytic anemia.叙述性综述：阵发性夜间血红蛋白尿症：补体相关溶血性贫血的生理学
Ann Intern Med. 2008 Apr 15;148(8):587-95. doi: 10.7326/0003-4819-148-8-200804150-00003.
2
A closer look at paroxysmal nocturnal hemoglobinuria.阵发性睡眠性血红蛋白尿症探秘。
Eur J Intern Med. 2010 Aug;21(4):260-7. doi: 10.1016/j.ejim.2010.04.002. Epub 2010 May 13.
3
[Eculizumab in paroxysmal nocturnal hemoglobinuria].[依库珠单抗治疗阵发性夜间血红蛋白尿]
Med Sci (Paris). 2009 Dec;25(12):1126-9. doi: 10.1051/medsci/200925121126.
4
[Paroxysmal nocturnal hemoglobinuria (PNH). Pathogenesis, diagnosis and treatment].[阵发性夜间血红蛋白尿（PNH）。发病机制、诊断与治疗]
Dtsch Med Wochenschr. 2009 Feb;134(9):404-9. doi: 10.1055/s-0028-1124013. Epub 2009 Feb 17.
5
[Paroxysmal nocturnal hemoglobinuria].[阵发性夜间血红蛋白尿]
Rev Med Interne. 2008 Nov;29(11):957-61. doi: 10.1016/j.revmed.2008.08.001. Epub 2008 Sep 17.
6
[Paroxysmal nocturnal hemoglobinuria: from physiopathology to treatment].[阵发性夜间血红蛋白尿：从病理生理学到治疗]
Rev Assoc Med Bras (1992). 2010 Mar-Apr;56(2):214-21. doi: 10.1590/s0104-42302010000200022.
7
New insights into paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿的新见解
Hematology. 2007 Oct;12(5):371-6. doi: 10.1080/10245330701562634.
8
[Attractiveness of paroxysmal nocturnal hemoglobinuria for study].
Rinsho Ketsueki. 2008 Oct;49(10):1330-40.
9
Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies.阵发性夜间血红蛋白尿症与补体系统：最新见解与新型抗补体策略。
Adv Exp Med Biol. 2013;735:155-72. doi: 10.1007/978-1-4614-4118-2_10.
10
Thrombosis in patients with paroxysmal nocturnal hemoglobinuria.阵发性睡眠性血红蛋白尿症患者的血栓形成。
Semin Thromb Hemost. 2011 Apr;37(3):315-21. doi: 10.1055/s-0031-1273095. Epub 2011 Mar 31.

引用本文的文献

1
Efficacy and safety of HRS-5965 monotherapy in complement inhibitor-naïve patients with paroxysmal nocturnal haemoglobinuria.HRS-5965单药治疗初治阵发性夜间血红蛋白尿补体抑制剂患者的疗效和安全性。
Br J Haematol. 2025 Aug;207(2):571-581. doi: 10.1111/bjh.20230. Epub 2025 Jun 30.
2
Effectiveness of Iptacopan Versus C5 Inhibitors in Complement Inhibitor-Naive Patients With Paroxysmal Nocturnal Haemoglobinuria.依普他单抗与C5抑制剂在初治阵发性夜间血红蛋白尿患者中的有效性比较
EJHaem. 2025 May 20;6(3):e270055. doi: 10.1002/jha2.70055. eCollection 2025 Jun.
3
Anchored Indirect Treatment Comparison Finds Comparable Effects of Pegcetacoplan and Iptacopan in Paroxysmal Nocturnal Haemoglobinuria.
锚定间接治疗比较发现培格西他单抗和依他库单抗在阵发性夜间血红蛋白尿中的疗效相当。
Eur J Haematol. 2025 Aug;115(2):125-133. doi: 10.1111/ejh.14422. Epub 2025 Apr 25.
4
EPYSQLI (SB12; Biosimilar to Reference Eculizumab) in Asian and Non-Asian Patients With Paroxysmal Nocturnal Hemoglobinuria: Subgroup Analysis of a Global Phase III Randomized Controlled Trial.依库珠单抗生物类似药（SB12；参照依库珠单抗的生物类似药）用于亚洲和非亚洲阵发性睡眠性血红蛋白尿患者：一项全球III期随机对照试验的亚组分析
EJHaem. 2025 Mar 21;6(2):e70020. doi: 10.1002/jha2.70020. eCollection 2025 Apr.
5
Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations.阵发性夜间血红蛋白尿：当前的管理、未满足的需求及建议
J Blood Med. 2023 Dec 6;14:613-628. doi: 10.2147/JBM.S431493. eCollection 2023.
6
Characteristics of paroxysmal nocturnal hemoglobinuria patients in Brazil: A retrospective administrative claims database analysis of PNH patients in Brazilian public healthcare system.巴西阵发性睡眠性血红蛋白尿症患者的特征：巴西公共医疗体系中阵发性睡眠性血红蛋白尿症患者的回顾性行政索赔数据库分析。
PLoS One. 2023 Jul 26;18(7):e0288708. doi: 10.1371/journal.pone.0288708. eCollection 2023.
7
Aplastic anemia and paroxysmal nocturnal hemoglobinuria in children and adults in two centers of Northern Greece.希腊北部两个中心儿童和成人的再生障碍性贫血和阵发性夜间血红蛋白尿
Front Oncol. 2022 Nov 10;12:947410. doi: 10.3389/fonc.2022.947410. eCollection 2022.
8
The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey.阵发性睡眠性血红蛋白尿症患者接受 C5 抑制剂依库珠单抗或拉维珠单抗治疗的疾病负担：来自美国患者调查的结果。
Ann Hematol. 2022 Feb;101(2):251-263. doi: 10.1007/s00277-021-04715-5. Epub 2022 Jan 1.
9
Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria.阵发性睡眠性血红蛋白尿诊断与治疗的共识声明
Hematol Transfus Cell Ther. 2021 Jul-Sep;43(3):341-348. doi: 10.1016/j.htct.2020.06.006. Epub 2020 Jul 6.
10
Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ).评估罕见病治疗的偏好：阵发性夜间血红蛋白尿患者偏好问卷（PNH-PPQ）的定性开发
Patient Prefer Adherence. 2020 Apr 5;14:705-715. doi: 10.2147/PPA.S233830. eCollection 2020.